68 / 100

Dr. Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award šŸ†

InformationĀ Technology atĀ  Ā Duhok Polytechnic UniversityšŸŽ“

Dr. Arunachalam Muthuraman is an Associate Professor in the Pharmacology Unit at AIMST University, Malaysia, with over 13 years of experience in pharmaceutical sciences. He holds an M. Pharm in Pharmacology and a Ph.D. in Neuropharmacology from Punjabi University, India. His research focuses on renal pharmacology, neuropharmacology, toxicology, cancer cell biology, and herbal technology. Dr. Muthuraman has published 84 research papers, 18 review articles, and authored multiple book chapters. His work has earned him prestigious recognitions, including the Elsevier Top 2% Scientist Rank in 2024 and the Global Top-50 Academician Award in 2023. He has guided numerous students, including Ph.D. candidates, and has contributed significantly to international conferences and workshops. Dr. Muthuraman is passionate about advancing pharmaceutical science and nurturing future researchers.

Professional ProfileĀ 

Education šŸŽ“:

Dr. Arunachalam Muthuraman holds a Bachelor of Pharmacy (B.Pharm) from The Tamilnadu Dr. MGR Medical University (2001-2005), a Master of Pharmacy (M.Pharm) in Pharmacology from Punjabi University (2005-2008), and a Ph.D. in Neuropharmacology from the same university (2008-2012). His academic foundation laid a strong base for his deep dive into pharmacology, particularly in neuropharmacology, renal pharmacology, and toxicology.

Work Experience šŸ’¼:

With over 13 years of academic experience, Dr. Muthuraman is currently an Associate Professor at AIMST University, Malaysia (2023-present), specializing in pharmacology. He has also held positions as Assistant Professor and Senior Lecturer in the Pharmacology Unit at AIMST University, demonstrating significant leadership and contributions to pharmacology education. Prior to this, he worked as an Associate Professor and Head of the Akal Pharmacology & Toxicology Research Centre at Akal College of Pharmacy, India.

Skills šŸ”

Dr. Muthuraman is skilled in diverse areas of pharmacology, including renal pharmacology, neuropharmacology, toxicology, and cancer cell biology. His expertise spans cellular and molecular pharmacology, cardiovascular pharmacology, and herbal technology, with a focus on drug research and development, clinical pharmacology, and technology-enhanced therapeutic solutions.

Awards and Honors šŸ†

Dr. Muthuraman has received prestigious recognitions, such as Elsevier’s Top 2% Scientist Rank in 2024, acknowledging his high impact research publications. He was also named in the Global Top-50 Academicians & Researchers of 2023 for his outstanding contributions to pharmaceutical sciences. Additionally, he was awarded the International Achievement Award in 2023 for his research contributions in pharmaceutical science.

šŸ¤ Memberships:

Dr. Muthuraman is actively involved in several international scientific communities and academic organizations, reflecting his dedication to advancing pharmaceutical research and education.

Teaching Experience šŸ‘©ā€šŸ«:

As a passionate educator, Dr. Muthuraman has guided numerous students at the Ph.D., M.Pharm, and B.Pharm levels. He has supervised 9 Ph.D. students, 25 M.Pharm students, and 39 B.Pharm students, contributing to the academic and professional growth of his students. His teaching focuses on imparting knowledge in pharmacology, toxicology, and drug research.

Research Focus šŸ”¬:

Dr. Muthuraman’s research is primarily focused on neuropharmacology, renal pharmacology, and toxicology, with an emphasis on discovering novel drug therapies for chronic diseases and cancer. His research on cellular & molecular pharmacology and the integration of herbal technology in drug development is also pioneering. He has published 84 research papers, authored 2 books, and contributed to numerous book chapters, demonstrating his leadership in academic research.

ConclusionĀ 

Dr. Arunachalam Muthuraman is an outstanding candidate for the Best Researcher Award, with his exceptional track record in pharmaceutical sciences, his contributions to advancing pharmacological research, and his commitment to mentoring future scholars. His continuous drive for excellence and innovative approach to research makes him a deserving recipient of this prestigious award.

šŸ“š Publilcation

    1. Therapeutic investigation of beta-carotene on diabetic retinopathy associated Alzheimer’s disease progression via the regulation of reactive glial cell functions in diabetic mice
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: Y Paramaswaran, A Muthuraman
    2. Beta-carotene ameliorates vascular dementia via modulation of homocysteine and endothelial nitric oxide synthase expression in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: KG Lim, A Muthuraman
    3. Therapeutic potential of beta-carotene on intracisternal injection of glucose oxidase-induced senile dementia in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: A Muthuraman, KG Lim
    4. Traditional Therapies Involving Nutrition for the Management of COVID-19
      • Year: 2024
      • Journal: Coronaviruses 5 (2), 40-48
      • Authors: R Muthusamy, A Muthuraman, K Anand
    5. NEUROBEHAVIORAL AND NEUROCHEMICAL EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORā€“GEFITINIB IN Ī’-AMYLOID OLIGOMER INDUCED ALZHEIMER’S DISEASE IN MICE MODEL
      • Year: 2024
      • Journal: Journal of Digital Economy 3 (1), 1-12
      • Authors: J Dhamodharan, G Sekhar, A Muthuraman
    6. Ameliorative potential of Astaxanthin on glyphosate-induced neurocognitive functional changes in adult zebrafish via acid phosphatase and annexin A2 dysfunction
      • Year: 2024
      • Journal: World 6 (01), 008-019
      • Authors: KZ Xuan, N Perveen, NH Khan, A Muthuraman
    7. Ameliorative potential of thymoquinone in four vessel occlusion induced vascular dementia in rats
      • Year: 2023
      • Journal: Alzheimer’s & Dementia 19, e071053
      • Authors: N Rishitha, A Muthuraman
    8. Preventive Action of Beta-Carotene against the Indoxyl Sulfate-Induced Renal Dysfunction in Male Adult Zebrafish via Regulations of Mitochondrial Inflammatory and Ī²-Carotene
      • Year: 2023
      • Journal: Biomedicines 11 (10), 2654
      • Authors: A Muthuraman, ASM Sayem, S Meenakshisundaram, N Ali, SF Ahmad, et al.
Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *